Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282639 · ClinicalTrials.gov registry record · NA
App-Based Certified Diabetes Education Therapy (AB-CDE)
A NA study, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT07282639 is a NA study that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 99 participants.
The verdict
NCT07282639, a NA study, has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to provide personalized recommendations for insulin dosing and carbohydrate intake during exercise or low blood sugar events. We want to find out if DailyDose can help lower blood sugar levels as measured by the hemoglobin A1c (HbA1c) test.
Interventions
- DEVICE DailyDose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2027-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07282639
The ClinicalTrials.gov registry entry for NCT07282639 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DailyDose is the first listed.
NCT07282639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07282639 about?
NCT07282639 is a clinical study titled "App-Based Certified Diabetes Education Therapy (AB-CDE)". The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to ...
What is the current status of trial NCT07282639?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2026-01-15. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT07282639?
The interventions under investigation include: DailyDose (DEVICE).
Who is sponsoring clinical trial NCT07282639?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.